Literature DB >> 18290725

Vitamin D toxicity, policy, and science.

Reinhold Vieth1.   

Abstract

The serum 25-hydroxyvitamin D [25(OH)D] concentration that is the threshold for vitamin D toxicity has not been established. Hypercalcemia is the hazard criterion for vitamin D. Past policy of the Institute of Medicine has set the tolerable upper intake level (UL) for vitamin D at 50 mug (2000 IU)/d, defining this as "the highest level of daily nutrient intake that is likely to pose no risks of adverse health effects to almost all individuals in the general population." However, because sunshine can provide an adult with vitamin D in an amount equivalent to daily oral consumption of 250 mug (10,000 IU)/d, this is intuitively a safe dose. The incremental consumption of 1 mug (40 IU)/day of vitamin D(3) raises serum 25(OH)D by approximately 1 nM (0.4 ng/ml). Therefore, if sun-deprived adults are to maintain serum 25(OH)D concentrations >75 nM (30 ng/ml), they will require an intake of more than the UL for vitamin D. The mechanisms that limit vitamin D safety are the capacity of circulating vitamin D-binding protein and the ability to suppress 25(OH)D-1-alpha-hydroxylase. Vitamin D causes hypercalcemia when the "free" concentration of 1,25-dihydroxyvitamin D is inappropriately high. This displacement of 1,25(OH)(2)D becomes excessive as plasma 25(OH)D concentrations become higher than at least 600 nM (240 ng/ml). Plasma concentrations of unmetabolized vitamin D during the first days after an acute, large dose of vitamin D can reach the micromolar range and cause acute symptoms. The clinical trial evidence shows that a prolonged intake of 250 mug (10,000 IU)/d of vitamin D(3) is likely to pose no risk of adverse effects in almost all individuals in the general population; this meets the criteria for a tolerable upper intake level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18290725     DOI: 10.1359/jbmr.07s221

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  66 in total

1.  Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism.

Authors:  Hulya Taskapan; Reinhold Vieth; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-06-05       Impact factor: 2.370

2.  Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study.

Authors:  Daniel V Dudenkov; Barbara P Yawn; Sara S Oberhelman; Philip R Fischer; Ravinder J Singh; Stephen S Cha; Julie A Maxson; Stephanie M Quigg; Tom D Thacher
Journal:  Mayo Clin Proc       Date:  2015-05       Impact factor: 7.616

3.  Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

Authors:  Yasuo Kusunoki; Isao Matsui; Takayuki Hamano; Akihiro Shimomura; Daisuke Mori; Sayoko Yonemoto; Yoshitsugu Takabatake; Yoshiharu Tsubakihara; René St-Arnaud; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

4.  High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial.

Authors:  Virginia A Stallings; Joan I Schall; Mary L Hediger; Babette S Zemel; Florin Tuluc; Kelly A Dougherty; Julia L Samuel; Richard M Rutstein
Journal:  Pediatr Infect Dis J       Date:  2015-02       Impact factor: 2.129

5.  Risks of the 'Sunshine pill' - a case of hypervitaminosis D.

Authors:  Sebastien Ellis; Georgios Tsiopanis; Tanuj Lad
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

Review 6.  Vitamin D in cutaneous carcinogenesis: part II.

Authors:  Jean Y Tang; Teresa Fu; Christopher Lau; Dennis H Oh; Daniel D Bikle; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

7.  Osteomalacia and vitamin D deficiency in a psychiatric rehabilitation unit: case report and survey.

Authors:  Rudolf N Cardinal; Carol A Gregory
Journal:  BMC Res Notes       Date:  2009-05-09

8.  Effect of vitamin D supplementation on bone health parameters of healthy young Indian women.

Authors:  Nidhi Malhotra; Ambrish Mithal; Sushil Gupta; Manoj Shukla; Madan Godbole
Journal:  Arch Osteoporos       Date:  2009-07-14       Impact factor: 2.617

Review 9.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

10.  VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome.

Authors:  Ursula Thiem; Georg Heinze; Rudolf Segel; Thomas Perkmann; Franz Kainberger; Ferdinand Mühlbacher; Walter Hörl; Kyra Borchhardt
Journal:  Trials       Date:  2009-05-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.